FTC Urges 2nd Circ. To Revive Bystolic Antitrust Case
The Federal Trade Commission urged the Second Circuit to revive claims from Bystolic buyers alleging that an AbbVie predecessor struck deals with several generic makers to delay competition for its hypertension...To view the full article, register now.
Already a subscriber? Click here to view full article